chlorambucil,venetoclax,obinutuzumab
abbvie,roche
['lymsm', 'cll14', 'leusm', 'cll']
6-yr f/u cll14 #17icml:
- no diff in spms between vo &amp; clb-o
- mpfs 6.3 yrs in vo arm
- mpfs 4.3 yrs if tp53mut with vo
- mpfs slightly worse in vo arm if ighv unmut
great option for pts who want time-limited therapy. tp53 data very important in clinical practice. #lymsm #leusm 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈